Dpheal Sul 16 Hot

Methylsulfonylmethane


Msmineral Co.,ltd.
Human Otc Drug
NDC 82409-020
Dpheal Sul 16 Hot also known as Methylsulfonylmethane is a human otc drug labeled by 'Msmineral Co.,ltd.'. National Drug Code (NDC) number for Dpheal Sul 16 Hot is 82409-020. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Dpheal Sul 16 Hot drug includes Dimethyl Sulfone - 10 g/100mL . The currest status of Dpheal Sul 16 Hot drug is Active.

Drug Information:

Drug NDC: 82409-020
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Dpheal Sul 16 Hot
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Methylsulfonylmethane
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Msmineral Co.,ltd.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Gel
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:DIMETHYL SULFONE - 10 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Nov, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 04 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:MSMINERAL CO.,Ltd.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:9H4PO4Z4FT
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
82409-020-01120 mL in 1 TUBE (82409-020-01)01 Nov, 2021N/ANo
82409-020-02100 mL in 1 TUBE (82409-020-02)01 Nov, 2021N/ANo
82409-020-0350 mL in 1 CONTAINER (82409-020-03)01 Nov, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose topical analgesic

Product Elements:

Dpheal sul 16 hot methylsulfonylmethane dimethyl sulfone dimethyl sulfone water butylene glycol alcohol

Indications and Usage:

Uses ■ provides support for joint and cartilage health.

Warnings:

Warnings ■ for external use only ■ when using cosmetics or immediately after use, if there are abnormal symptoms or side effects such as red spots, swelling, or itching due to direct sunlight, consult a specialist. ■ keep out of reach of children

Dosage and Administration:

Directions ■ before and after exercise, apply the appropriate amount to the desired area and massage. (waist, shoulder, arm, knee, ankle, calf, etc.) be careful with your face or sensitive body parts.when used by children, adult supervision is required.

Package Label Principal Display Panel:

Dpheal sul 16 hot 120ml ndc: 82409-020-01 image of tube

Dpheal sul 16 hot 100ml ndc: 82409-020-02 image of tube

Dpheal sul 16 hot 50ml ndc: 82409-020-03 image of container

Further Questions:

Questions ■ customer service center : 1-770-878-3322 ■ homepage : http://www.msmmineral.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.